Objectives: To determine the rate of patients prescribed and the average dose of Angiotensin-converting enzyme inhibitors (ACE inhibitors), angiotensin receptor blockers (ARB), mineralocorticoid receptor antagonists (MRAs) and angiotensin receptor-neprilysin inhibitor (ARNI) drug.